Drug and alcohol review最新文献

{"title":"'Moderation Is the Holy Grail': The Acceptability of 'Sober Curious' Tools for Alcohol Reduction Among Midlife Women.","authors":"Belinda Lunnay, Sarah MacLean, Tonda Hughes, Amy Pennay, Paul R Ward","doi":"10.1111/dar.14085","DOIUrl":"https://doi.org/10.1111/dar.14085","url":null,"abstract":"<p><strong>Introduction: </strong>Midlife Australian women are a population group in which alcohol consumption is not decreasing across generations, as in other groups. We explored midlife women's perceptions and experiences of engaging with sober curious tools (self-guided programs, apps, literature, podcasts, online forums) to determine the acceptability of such tools among those seeking to reduce drinking.</p><p><strong>Method: </strong>Qualitative interviews with 26 Australian women (aged 45-64) of varying social classes, work and relationship statuses living in Adelaide/Melbourne/Sydney who self-reported heavy/medium drinking during 2021. We applied Sekhon et al.'s 'acceptability of healthcare interventions' framework to understand components that increase the acceptability of sober curious tools and an abductive logic to explain the mechanisms that impact acceptability.</p><p><strong>Results: </strong>Acceptability was stronger among women who felt a sense of security and belonging when tools cohered with their preparedness to reduce drinking and accounted for their perceptions about feasible reductions. Importantly, sober curious tools increased the acceptability of reducing alcohol by increasing women's agency to 'question' heavy-drinking norms, especially when combined with social supports. It is important to women that they envisage themselves as the intended 'user' of sober curious tools. Acceptability differed for women based on social class inequities that result in marginalisation and that intersect with stigma because of ageism.</p><p><strong>Discussion and conclusions: </strong>Sober curious tools are most acceptable to middle class and affluent women and represent capacities to reduce alcohol consumption. Understanding the experiences of diverse groups of women and their agency to engage with sober curiosity is important to inform future interventions.</p>","PeriodicalId":11318,"journal":{"name":"Drug and alcohol review","volume":" ","pages":""},"PeriodicalIF":3.0,"publicationDate":"2025-05-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144186784","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"A Scoping Review of the Emergence of Novel Synthetic Opioids in Australian Drug Markets: What Does This Mean for Harm Reduction Responses?","authors":"Emmanuel Mammoliti, Suzanne Nielsen, Amanda Roxburgh","doi":"10.1111/dar.14079","DOIUrl":"https://doi.org/10.1111/dar.14079","url":null,"abstract":"<p><strong>Issues: </strong>Rising synthetic opioid deaths in North America, and the emergence of nitazene harms has driven concern about novel synthetic opioids (NSO) in Australia. This scoping review aimed to map what is known about NSOs in Australia.</p><p><strong>Approach: </strong>Scoping review of peer-reviewed and grey literature on NSO detections and harms.</p><p><strong>Criteria: </strong>studies describing NSO market indicators and harms in Australia.</p><p><strong>Key findings: </strong>Overall, 912 peer-reviewed studies were identified; 40 met criteria. Monitoring systems identified NSOs (e.g., β-U10, nitazenes) for the first time in Australia. Nitazene toxicity appeared in emergency departments (N = 11, 2021-onwards), two involved intentional consumption. NSOs for sale to Australia on cryptomarkets comprised < 1% of drug listings. Mortality studies identified fentanyl analogues (furanylfentanyl, acetylfentanyl) (N = 22, 2013-2021), and other NSO U-47700; (N = 12, 2016-2021) deaths. Thirty-three nitazene deaths were reported; 24 in Victoria (2021-onwards); 7 in SA (2022-onwards); two in NSW (2024). Australian Federal Police reported 47 nitazene seizures since July 2023. Fifty-one drug alerts were identified (2019-2024); 18 (34%) involved NSOs; 12 (24%) for nitazenes. Overall, 12 alerts were for NSO-contaminated stimulants; at least two fatal overdoses were confirmed due to NSO-contaminated stimulants.</p><p><strong>Implications: </strong>Australia has strong monitoring capacity for NSOs post-consumption. Harms occurring among opioid-naïve people unknowingly purchasing NSOs suggest a role for drug checking and cautious use of nitazene testing strips. Expanding take-home naloxone availability in entertainment settings, and to all who use drugs, is warranted.</p><p><strong>Conclusion: </strong>This review demonstrated the recent and limited emergence of NSOs in Australia. Demand for NSOs is not yet clear; availability and harms are rapidly changing.</p>","PeriodicalId":11318,"journal":{"name":"Drug and alcohol review","volume":" ","pages":""},"PeriodicalIF":3.0,"publicationDate":"2025-05-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144173036","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Patterns of Acute Gamma-Hydroxybutyrate Harms Requiring Ambulance Attendance: Should Greater Focus Be on Regional Areas?","authors":"Naomi Beard, James Wilson, Bosco C Rowland, Ziad Nehme, Dan I Lubman, Rowan P Ogeil","doi":"10.1111/dar.14086","DOIUrl":"https://doi.org/10.1111/dar.14086","url":null,"abstract":"<p><strong>Introduction: </strong>Gamma-hydroxybutyrate (GHB) use and attributable harms have been increasing in Europe and Australia. However, there are limited population surveillance tools available to map and track acute GHB-related harms, particularly outside metropolitan areas. The present study examined GHB-related ambulance attendances from January 2015 to March 2024 across the state of Victoria, and in Greater Geelong, the region associated with the highest number of attendances outside the state capital.</p><p><strong>Methods: </strong>Retrospective analysis of all GHB-related ambulance attendances between 1 January 2015 and 31 March 2024 from the Victorian arm of the National Ambulance Surveillance System. Descriptives and time series analyses were used to present demographic and spatio-temporal patterns.</p><p><strong>Results: </strong>There were 16,971 ambulance attendances for GHB during the study period. A sinusoidal trend was apparent in the statewide data, suggesting a seasonal factor to GHB-related attendances, with greater numbers occurring during quarter four of each year. Whilst a seasonal effect was also apparent in Greater Geelong, increases in attendances have been consistent since quarter four of 2021 (between 7% and 34%). The magnitude of these increases was not observed in other regional areas.</p><p><strong>Discussion and conclusions: </strong>Acute GHB-related harms have increased in Victoria over time, in addition to a seasonal effect being apparent that coincided with summer in the Southern Hemisphere. Our findings support recent media reports from emergency department workers in the region of Greater Geelong that GHB harms have risen. This study demonstrates the value of using ambulance surveillance data to assess pre-hospital harms resulting from GHB use.</p>","PeriodicalId":11318,"journal":{"name":"Drug and alcohol review","volume":" ","pages":""},"PeriodicalIF":3.0,"publicationDate":"2025-05-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144173040","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Portuguese Validated Versions of the Alcohol Use Disorders Identification Test: A Systematic Review of Academic and Grey Literature.","authors":"Diogo Phalempin Cardoso, Daniela Oliveira, Beatriz Antunes, Rosa Saraiva, Kathryn Angus, Eugenia Gallardo, Frederico Rosário","doi":"10.1111/dar.14081","DOIUrl":"https://doi.org/10.1111/dar.14081","url":null,"abstract":"<p><strong>Issues: </strong>The Alcohol Use Disorders Identification Test (AUDIT) is one of the best screening instruments for at-risk drinkers. However, a fully validated Portuguese version is lacking. This study aimed to review validated versions of the AUDIT in Portuguese and their characteristics.</p><p><strong>Approach: </strong>A systematic search was performed in Ovid MEDLINE, CINAHL, PsycINFO, ÍndexRMP, LILACS, AJOL and Scielo databases, along with grey literature searches. Two authors independently extracted data and assessed the studies' methodological quality, using the QUADAS-2 checklist.</p><p><strong>Key findings: </strong>Seven studies were included in this review, six from Brazil and the other from Portugal, in a total of three versions of the AUDIT achieved through translation-back translation. Studies reported acceptable to good internal consistency (Cronbach α = 0.72-0.86), moderate to excellent inter-rater reliability (K = 0.75-0.99), and poor to moderate test-retest reliability (K = 0.52-0.75). Sensitivity ranged from 52.2% to 100% and specificity from 64% to 98.9%. Only two studies reported on AUC, with values between 0.805 and 0.858. No study reported on all the performance characteristics and psychometric properties. The Portuguese translations for terms lacking a direct translation from English were heterogeneous.</p><p><strong>Implications: </strong>This review could not identify any studies rigorously validating the AUDIT in Portuguese, raising concerns regarding the AUDIT's validity as a screening tool in Portugal and other Portuguese-speaking countries. The significant variation between versions raises questions regarding its efficacy.</p><p><strong>Conclusion: </strong>The results of this review show the need for a validation study of the AUDIT in Portugal and other Portuguese-speaking countries and the development of a new version for Portugal.</p>","PeriodicalId":11318,"journal":{"name":"Drug and alcohol review","volume":" ","pages":""},"PeriodicalIF":3.0,"publicationDate":"2025-05-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144149655","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Exploring Socio-Demographic Characteristics of Caregivers Who Indicated a Child Was Substantially Affected by Others' Drinking in Australia.","authors":"Cassandra Hopkins, Sandra Kuntsche, Robyn Dwyer, Heng Jiang, Anne-Marie Laslett","doi":"10.1111/dar.14087","DOIUrl":"https://doi.org/10.1111/dar.14087","url":null,"abstract":"<p><strong>Introduction: </strong>Children's health and wellbeing is influenced by the social, economic and environmental conditions in which they live, known as the social determinants of health (SDH). This study examines caregivers' socio-demographic characteristics and reports of children substantially affected by others' drinking (i.e., caregivers' interpretations of severity).</p><p><strong>Methods: </strong>A sample of 705 adults living with children under 18 years from the 2021 Australian Alcohol's Harm to Others study indicated how much a child was negatively affected by others' drinking (excluding their own) in the past year. Responses were categorised as 'substantially affected' or 'less substantially affected'. Logistic regressions examined associations of socio-demographic characteristics and reports of substantially affected children.</p><p><strong>Results: </strong>Amongst caregivers, 5.4% indicated a child was substantially affected by others' drinking in the past year. Identifying as a woman (95% CI 1.17-5.13, p = 0.017), experiencing financial stress (95% CI 2.01-7.70, p = 0.000), being a single caregiver (95% CI 1.35-6.56, p = 0.007) or living in an area with a lower Socio-Economic Indexes for Areas score (95% CI 1.03-3.94, p = 0.039) was associated with an increased likelihood of indicating a child was substantially affected by others' drinking.</p><p><strong>Discussion and conclusions: </strong>Our findings highlight that caregiver social disadvantage is associated with indicating a child was substantially affected by others' drinking. Policies addressing alcohol consumption and social disadvantage affecting children's wellbeing are needed, particularly financial support for families experiencing financial stress and single caregivers. Larger and more targeted studies are needed to further examine SDH and outcomes for children related to others' drinking.</p>","PeriodicalId":11318,"journal":{"name":"Drug and alcohol review","volume":" ","pages":""},"PeriodicalIF":3.0,"publicationDate":"2025-05-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144149751","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Contents and Time-Course of Falsified Alprazolam Detections in New South Wales, Australia.","authors":"Janette L Smith, Thanjira Jiranantakan, Una Cullinan, Christopher Ewers, Darren M Roberts, Jared A Brown","doi":"10.1111/dar.14068","DOIUrl":"https://doi.org/10.1111/dar.14068","url":null,"abstract":"<p><strong>Introduction: </strong>Falsified alprazolam tablets (sometimes called 'counterfeit alprazolam') typically do not contain alprazolam and instead contain novel benzodiazepines or other drugs. We describe temporal changes in the number and contents of falsified alprazolam tablets in New South Wales, Australia.</p><p><strong>Methods: </strong>We searched a database of analysed police seizures between January 2012 and March 2024 for falsified alprazolam (tablet presenting as Kalma, Mylan, Xanax, Sandoz or Alprax brands, but not containing alprazolam and/or contained other drugs). Falsified alprazolam tablets taken by patients presenting to NSW Health services for 5 months in 2020 were also tested.</p><p><strong>Results: </strong>We identified 809 falsified alprazolam tablet seizures, mostly Xanax (n = 406, 50%) or Mylan (n = 322, 40%) brands. The three most common drugs detected in falsified alprazolam tablets were the novel benzodiazepines etizolam (present in n = 228 samples, 28%), clonazolam (n = 224, 28%) and bromazolam (n = 178, 22%). Of all falsified alprazolam tablets, only 70 (8.7%) contained alprazolam. There were rare detections of non-benzodiazepine drugs including the opioids etodesnitazene and ortho-desmethyltramadol.</p><p><strong>Discussion and conclusions: </strong>Our analysis highlights the variability in contents of falsified alprazolam tablets over time. This report highlights the potential value of surveillance systems involving analysis of police seizure data as part of a drug early warning system. Our results are of interest to the community who take falsified alprazolam tablets, and to health care workers managing cases of poisoning or dependence. This study highlights the need to continue developing the ability to detect, assess and respond to emerging falsified products, to facilitate clinical and public health responses.</p>","PeriodicalId":11318,"journal":{"name":"Drug and alcohol review","volume":" ","pages":""},"PeriodicalIF":3.0,"publicationDate":"2025-05-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144132188","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Gender Differences in Alcohol Research: A Focus on How Men and Women Are Studied in Australia and Aotearoa New Zealand.","authors":"Megan Cook, Amy Pennay, Sarah MacLean, Gabriel Caluzzi, Benjamin Riordan, Amanda Cooklin, Alexandra Torney, Sarah Callinan","doi":"10.1111/dar.14083","DOIUrl":"https://doi.org/10.1111/dar.14083","url":null,"abstract":"","PeriodicalId":11318,"journal":{"name":"Drug and alcohol review","volume":" ","pages":""},"PeriodicalIF":3.0,"publicationDate":"2025-05-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144101668","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Estimating the Prevalence and Correlates of Problematic Alcohol Use Among Patients Treated for Illicit Substance Disorder in France, 2012-2022.","authors":"Eric Janssen, Mike Vuolo, Sophie Véron, Ivette Flores Laffont","doi":"10.1111/dar.14078","DOIUrl":"https://doi.org/10.1111/dar.14078","url":null,"abstract":"<p><strong>Introduction: </strong>Alcohol use among patients in treatment for illicit substance use disorder (SUD) is often overlooked, at best perceived as a secondary issue, despite growing evidence of exacerbated negative health outcomes among polysubstance users.</p><p><strong>Method: </strong>We analyse a nationwide dataset on patients entering treatment for cannabis, opioid, and stimulant use disorders in France between 2012 and 2022. We conduct multilevel logistic regressions to determine the main predictors of problematic alcohol use (PAU) among patients who entered treatment for cannabis (n = 308,906), opioid (n = 255,879) or stimulant (n = 60,211) use disorders.</p><p><strong>Results: </strong>PAU remains a common behaviour among patients with SUD (overall prevalence: 28.2%, 95% confidence interval [CI] 28.1-28.3), with lower prevalence among patients treated for cannabis (27.3%, 95% CI 27.2-27.5) and opioid disorders (27.2%, 95% CI 27.0-27.4), and higher for patients treated for stimulant disorders (36.8%, 95% CI 36.4-37.2). There is an increase in PAU over time for each of the SUD leading to treatment (23.0% in 2012 vs. 29.5% in 2022; 23.3% vs. 31.4% and 29.7% vs. 38.9% respectively). Males, older people, early onset, current use of tobacco, and psychiatric comorbidities are positively associated with PAU.</p><p><strong>Discussion and conclusions: </strong>The increasing prevalence of problematic alcohol use among patients treated for SUD in France remains a source of concern. Screening for both alcohol and drug use among patients in treatment presents a crucial opportunity to prevent and treat SUDs early, especially among patients treated for stimulants.</p>","PeriodicalId":11318,"journal":{"name":"Drug and alcohol review","volume":" ","pages":""},"PeriodicalIF":3.0,"publicationDate":"2025-05-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144092845","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"E-cigarette use among gender and sexuality diverse (LGBTQA+) adolescents in Australia: The case for LGBTQA+ affirmative harm reduction.","authors":"Sasha Bailey, Emma L Barrett, Scarlett Smout, Lucinda Grummitt, Lyra Egan, Lauren Gardner, Emily A Stockings, Maree Teesson, Yael Perry, Nicola C Newton","doi":"10.1111/dar.14052","DOIUrl":"https://doi.org/10.1111/dar.14052","url":null,"abstract":"<p><strong>Introduction: </strong>This study aimed to provide a first-ever comprehensive epidemiology of vaping behaviours among Australian gender and sexuality diverse (LGBTQA+) youth.</p><p><strong>Methods: </strong>Using cross-sectional data from the Health4Life study, (N = 4,445 students, Mage = 15.7yrs), descriptive statistics and hierarchical mixed effects logistic regression models with nested random intercepts were used to calculate prevalence and differences in vaping behaviours by gender (trans [n = 142] vs. cisgender [n = 4,144]) and sexuality (gay or lesbian [n = 77], bisexual [n = 279], questioning [n = 167], queer [n = 90] vs. heterosexual [n = 3,638]), and associations of vaping with use of cigarettes and alcohol (including binge drinking), depression, and anxiety.</p><p><strong>Results: </strong>Over one-third of trans and bisexual adolescents had ever tried vaping. Trans adolescents were significantly more likely to report ever vaping, daily vaping, and intention to vape in the future, compared with their cisgender peers, irrespective of age, socio-economic status, and school. Relative to heterosexual peers, gay/lesbian adolescents were nearly three times as likely to report current regular use of vaping and bisexual adolescents were significantly more likely to report ever vaping and intentions to vape in the future. Among LGBTQA+ adolescents, ever using a vape was associated with increased odds of ever using cigarettes, ever binge drinking, ever drinking alcohol alone, probable depressive/anxiety disorders.</p><p><strong>Discussion: </strong>Vaping is significantly more common among LGBTQA+ adolescents, especially trans and bisexual adolescents, compared with their cisgender, heterosexual peers. Government health and education bodies should partner with LGBTQA+ community organisations to address the unique contexts of vaping among LGBTQA+ young people in an LGBTQA+ affirmative harm reduction manner.</p>","PeriodicalId":11318,"journal":{"name":"Drug and alcohol review","volume":" ","pages":""},"PeriodicalIF":3.0,"publicationDate":"2025-05-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144092611","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Alcohol Use in the Early Postpartum Period: An Ecological Momentary Assessment Study to Understand the Role of Self-Efficacy.","authors":"Sarah Dauber, Janardan Devkota, Alexa Beacham, Allison West, Minerva Francis, Timothy Regan, Johannes Thrul","doi":"10.1111/dar.14076","DOIUrl":"https://doi.org/10.1111/dar.14076","url":null,"abstract":"<p><strong>Introduction: </strong>This study investigated daily associations between maternal self-efficacy (MSE), drinking self-efficacy (DSE), alcohol urges and alcohol use in the first 6 weeks postpartum, with the goal of informing a tailored just-in-time adaptive intervention for postpartum alcohol use.</p><p><strong>Methods: </strong>Ecological momentary assessment was conducted with 37 postpartum mothers with pre-pregnancy at-risk alcohol use. Participants completed surveys on their smartphones five times a day for 14 days and reported on MSE, DSE, urge to drink and alcohol use.</p><p><strong>Results: </strong>Both MSE and DSE demonstrated within-subject variability. MSE and DSE were significantly positively correlated. MSE reported in the morning significantly predicted the likelihood of drinking that day. DSE was not associated with daily drinking. Neither MSE nor DSE were associated with the urge to drink.</p><p><strong>Discussion and conclusions: </strong>Both MSE and DSE demonstrated greater within-person change across days than within a single day, and MSE showed more stability than DSE at the within-person level. Lower reported MSE in the morning was associated with a greater likelihood of drinking that day. MSE may be a more important intervention target than DSE in the postpartum population. These findings will directly inform just-in-time adaptive intervention development. Future research will examine momentary associations among these constructs and explore contextual factors influencing MSE and DSE fluctuations.</p>","PeriodicalId":11318,"journal":{"name":"Drug and alcohol review","volume":" ","pages":""},"PeriodicalIF":3.0,"publicationDate":"2025-05-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143996111","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}